Catalent Stock Price and Value Analysis

Should you buy Catalent stock? (NYSE:CTLT). Let's see how it does in our automated value investing analysis system.

CTLT Free Cash Flow Trend

Free Cash Flow trendline for CTLT
Free Cash Flow trendline for Catalent

Based on historical returns, we believe that Catalent can grow its free cash at a rate of about 1%. That's positive!

  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the CTLT Numbers

CTLT Price
(Catalent stock price per share)
[?] CTLT Fair Price
(based on intrinsic value)
[?] CTLT Safety Price (based on a variable margin of safety) $4.48
[?] PE Ratio versus Sector 160% higher than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Free Cash Flow Jitter 51%

Is Catalent Stock on Sale?

We believe that Catalent may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Catalent looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CTLT Stock?

Does Catalent have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.